Metabolic Bone Diseases and Osteoporosis

Metabolic bone diseases encompass a group of disorders characterized by abnormalities in bone metabolism, leading to decreased bone density and increased fracture risk. Osteoporosis, the most common metabolic bone disease, results from an imbalance between bone formation and resorption, often exacerbated by hormonal changes, nutritional deficiencies, or aging. Management strategies focus on optimizing bone health through lifestyle modifications, pharmacotherapy, and fracture prevention strategies. Research efforts aim to unravel the complex pathophysiology of bone diseases and develop targeted therapies to mitigate skeletal fragility and reduce the burden of osteoporotic fractures.

    Related Conference of Metabolic Bone Diseases and Osteoporosis

    May 14-15, 2026

    7th World Summit on Diabetes

    Rome, Italy
    May 18-19, 2026

    57th Annual Congress on Endocrinology and Diabetes Research

    Aix-en-Provence, France
    June 22-23, 2026

    16th World Congress on Endocrinology and Diabetes

    Paris, France
    July 20-21, 2026

    6th World Congress on Endocrine and Diabetes

    Paris, France
    July 20-21, 2026

    6th Annual Summit on Diabetes and Endocrinology

    Paris, France
    August 17-18, 2026

    4th World congress and Expo on Diabetes

    Toronto, Canada
    September 29-30, 2026

    22nd World Congress on Endocrinology & Diabetes

    Paris, France

    Metabolic Bone Diseases and Osteoporosis Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in